Ozer, M.; Vegivinti, C.T.R.; Syed, M.; Ferrell, M.E.; Gonzalez Gomez, C.; Cheng, S.; Holder-Murray, J.; Bruno, T.; Saeed, A.; Sahin, I.H.
Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm. Cancers 2023, 15, 3833.
https://doi.org/10.3390/cancers15153833
AMA Style
Ozer M, Vegivinti CTR, Syed M, Ferrell ME, Gonzalez Gomez C, Cheng S, Holder-Murray J, Bruno T, Saeed A, Sahin IH.
Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm. Cancers. 2023; 15(15):3833.
https://doi.org/10.3390/cancers15153833
Chicago/Turabian Style
Ozer, Muhammet, Charan Thej Reddy Vegivinti, Masood Syed, Morgan E. Ferrell, Cyndi Gonzalez Gomez, Svea Cheng, Jennifer Holder-Murray, Tullia Bruno, Anwaar Saeed, and Ibrahim Halil Sahin.
2023. "Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm" Cancers 15, no. 15: 3833.
https://doi.org/10.3390/cancers15153833
APA Style
Ozer, M., Vegivinti, C. T. R., Syed, M., Ferrell, M. E., Gonzalez Gomez, C., Cheng, S., Holder-Murray, J., Bruno, T., Saeed, A., & Sahin, I. H.
(2023). Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm. Cancers, 15(15), 3833.
https://doi.org/10.3390/cancers15153833